Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Liver Failure Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Liver Failure Therapeuticsmarket, defines the market attractiveness level of Liver Failure Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Liver Failure Therapeutics industry, describes the types of Liver Failure Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Liver Failure Therapeutics market and the development prospects and opportunities of Liver Failure Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Liver Failure Therapeutics market in Chapter 13.
By Player:
Ventria Bioscience
Mina Therapeutics Ltd
Unicyte AG
Silence Therapeutics Plc
Mylan NV
Conatus Pharmaceuticals Inc
Immune Pharmaceuticals Inc
Promethera Biosciences SA
Alfact Innovation
BioLineRx Ltd
Cell2B Advanced Therapeutics SA
Ocera Therapeutics Inc
PledPharma AB
Vital Therapies Inc
By Type:
Ornithine Phenylacetate
MTL-CEBPA
F-573
BL-1220
PP-100
Others
By End-User:
Clinic
Hospital
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Liver Failure Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Liver Failure Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Liver Failure Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Liver Failure Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Liver Failure Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Liver Failure Therapeutics Consumption (2017-2022)
-
7.2 United States Liver Failure Therapeutics Consumption (2017-2022)
-
7.3 Europe Liver Failure Therapeutics Consumption (2017-2022)
-
7.4 China Liver Failure Therapeutics Consumption (2017-2022)
-
7.5 Japan Liver Failure Therapeutics Consumption (2017-2022)
-
7.6 India Liver Failure Therapeutics Consumption (2017-2022)
-
7.7 South Korea Liver Failure Therapeutics Consumption (2017-2022)
8 Region and Country-wise Liver Failure Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Liver Failure Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Liver Failure Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Liver Failure Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Liver Failure Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Liver Failure Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Liver Failure Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Liver Failure Therapeutics Consumption Forecast (2022-2028)
9 Global Liver Failure Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Liver Failure Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Ornithine Phenylacetate Consumption and Growth Rate (2017-2022)
-
9.1.2 Global MTL-CEBPA Consumption and Growth Rate (2017-2022)
-
9.1.3 Global F-573 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global BL-1220 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global PP-100 Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Liver Failure Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Liver Failure Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Liver Failure Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Ornithine Phenylacetate Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global MTL-CEBPA Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global F-573 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global BL-1220 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global PP-100 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Liver Failure Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Liver Failure Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Liver Failure Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Liver Failure Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Liver Failure Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Liver Failure Therapeutics Market Competitive Analysis
-
14.1 Ventria Bioscience
-
14.1.1 Ventria Bioscience Company Details
-
14.1.2 Ventria Bioscience Liver Failure Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Ventria Bioscience Liver Failure Therapeutics Product and Service
-
14.2 Mina Therapeutics Ltd
-
14.2.1 Mina Therapeutics Ltd Company Details
-
14.2.2 Mina Therapeutics Ltd Liver Failure Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Mina Therapeutics Ltd Liver Failure Therapeutics Product and Service
-
14.3 Unicyte AG
-
14.3.1 Unicyte AG Company Details
-
14.3.2 Unicyte AG Liver Failure Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Unicyte AG Liver Failure Therapeutics Product and Service
-
14.4 Silence Therapeutics Plc
-
14.4.1 Silence Therapeutics Plc Company Details
-
14.4.2 Silence Therapeutics Plc Liver Failure Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Silence Therapeutics Plc Liver Failure Therapeutics Product and Service
-
14.5 Mylan NV
-
14.5.1 Mylan NV Company Details
-
14.5.2 Mylan NV Liver Failure Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Mylan NV Liver Failure Therapeutics Product and Service
-
14.6 Conatus Pharmaceuticals Inc
-
14.6.1 Conatus Pharmaceuticals Inc Company Details
-
14.6.2 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Product and Service
-
14.7 Immune Pharmaceuticals Inc
-
14.7.1 Immune Pharmaceuticals Inc Company Details
-
14.7.2 Immune Pharmaceuticals Inc Liver Failure Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Immune Pharmaceuticals Inc Liver Failure Therapeutics Product and Service
-
14.8 Promethera Biosciences SA
-
14.8.1 Promethera Biosciences SA Company Details
-
14.8.2 Promethera Biosciences SA Liver Failure Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Promethera Biosciences SA Liver Failure Therapeutics Product and Service
-
14.9 Alfact Innovation
-
14.9.1 Alfact Innovation Company Details
-
14.9.2 Alfact Innovation Liver Failure Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Alfact Innovation Liver Failure Therapeutics Product and Service
-
14.10 BioLineRx Ltd
-
14.10.1 BioLineRx Ltd Company Details
-
14.10.2 BioLineRx Ltd Liver Failure Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 BioLineRx Ltd Liver Failure Therapeutics Product and Service
-
14.11 Cell2B Advanced Therapeutics SA
-
14.11.1 Cell2B Advanced Therapeutics SA Company Details
-
14.11.2 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Product and Service
-
14.12 Ocera Therapeutics Inc
-
14.12.1 Ocera Therapeutics Inc Company Details
-
14.12.2 Ocera Therapeutics Inc Liver Failure Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Ocera Therapeutics Inc Liver Failure Therapeutics Product and Service
-
14.13 PledPharma AB
-
14.13.1 PledPharma AB Company Details
-
14.13.2 PledPharma AB Liver Failure Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 PledPharma AB Liver Failure Therapeutics Product and Service
-
14.14 Vital Therapies Inc
-
14.14.1 Vital Therapies Inc Company Details
-
14.14.2 Vital Therapies Inc Liver Failure Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Vital Therapies Inc Liver Failure Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Liver Failure Therapeutics
-
Figure Liver Failure Therapeutics Picture
-
Table Global Liver Failure Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Liver Failure Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Liver Failure Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Liver Failure Therapeutics Consumption by Country (2017-2022)
-
Figure United States Liver Failure Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Liver Failure Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Liver Failure Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Liver Failure Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Liver Failure Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Liver Failure Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Liver Failure Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Liver Failure Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Liver Failure Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Liver Failure Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Liver Failure Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Liver Failure Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Liver Failure Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ornithine Phenylacetate Consumption and Growth Rate (2017-2022)
-
Figure Global MTL-CEBPA Consumption and Growth Rate (2017-2022)
-
Figure Global F-573 Consumption and Growth Rate (2017-2022)
-
Figure Global BL-1220 Consumption and Growth Rate (2017-2022)
-
Figure Global PP-100 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Ornithine Phenylacetate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global MTL-CEBPA Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global F-573 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global BL-1220 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PP-100 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Liver Failure Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Liver Failure Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Ventria Bioscience (Foundation Year, Company Profile and etc.)
-
Table Ventria Bioscience Liver Failure Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ventria Bioscience Liver Failure Therapeutics Product and Service
-
Table Mina Therapeutics Ltd (Foundation Year, Company Profile and etc.)
-
Table Mina Therapeutics Ltd Liver Failure Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mina Therapeutics Ltd Liver Failure Therapeutics Product and Service
-
Table Unicyte AG (Foundation Year, Company Profile and etc.)
-
Table Unicyte AG Liver Failure Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Unicyte AG Liver Failure Therapeutics Product and Service
-
Table Silence Therapeutics Plc (Foundation Year, Company Profile and etc.)
-
Table Silence Therapeutics Plc Liver Failure Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Silence Therapeutics Plc Liver Failure Therapeutics Product and Service
-
Table Mylan NV (Foundation Year, Company Profile and etc.)
-
Table Mylan NV Liver Failure Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan NV Liver Failure Therapeutics Product and Service
-
Table Conatus Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Conatus Pharmaceuticals Inc Liver Failure Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Conatus Pharmaceuticals Inc Liver Failure Therapeutics Product and Service
-
Table Immune Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Immune Pharmaceuticals Inc Liver Failure Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Immune Pharmaceuticals Inc Liver Failure Therapeutics Product and Service
-
Table Promethera Biosciences SA (Foundation Year, Company Profile and etc.)
-
Table Promethera Biosciences SA Liver Failure Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Promethera Biosciences SA Liver Failure Therapeutics Product and Service
-
Table Alfact Innovation (Foundation Year, Company Profile and etc.)
-
Table Alfact Innovation Liver Failure Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alfact Innovation Liver Failure Therapeutics Product and Service
-
Table BioLineRx Ltd (Foundation Year, Company Profile and etc.)
-
Table BioLineRx Ltd Liver Failure Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioLineRx Ltd Liver Failure Therapeutics Product and Service
-
Table Cell2B Advanced Therapeutics SA (Foundation Year, Company Profile and etc.)
-
Table Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Product and Service
-
Table Ocera Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Ocera Therapeutics Inc Liver Failure Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ocera Therapeutics Inc Liver Failure Therapeutics Product and Service
-
Table PledPharma AB (Foundation Year, Company Profile and etc.)
-
Table PledPharma AB Liver Failure Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table PledPharma AB Liver Failure Therapeutics Product and Service
-
Table Vital Therapies Inc (Foundation Year, Company Profile and etc.)
-
Table Vital Therapies Inc Liver Failure Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vital Therapies Inc Liver Failure Therapeutics Product and Service
-
